• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒感染的动物模型。

Animal models of HBV infection.

作者信息

Dandri Maura, Petersen Joerg

机构信息

I. Department of Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF) Hamburg-Lübeck-Borstel Site, Germany.

IFI Institute for Interdisciplinary Medicine at Asklepios Clinic St. Georg, Hamburg, Germany.

出版信息

Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):273-279. doi: 10.1016/j.bpg.2017.04.014. Epub 2017 May 5.

DOI:10.1016/j.bpg.2017.04.014
PMID:28774409
Abstract

The mechanisms determining hepatitis B virus (HBV) persistence and pathogenesis are not fully elucidated, but appear to be multi-factorial. Current medication to repress viral replication is available; however, the unique replication strategies employed by HBV enable the virus to persist within the infected hepatocytes. Consequently, cure is rarely achieved. Progresses in HBV research and preclinical testing of antiviral agents have been limited by the narrow species- and tissue-tropism of the virus, the paucity of infection models available and the restrictions imposed by the use of chimpanzees, the only animals fully susceptible to HBV infection. Mice are not HBV permissive but major efforts have focused on the development of mouse models of HBV replication and infection, such as the generation of humanized mice. By presenting the different animal models available, this review will highlight the most important and clinically relevant findings that have been retrieved from the respective systems.

摘要

决定乙型肝炎病毒(HBV)持续存在和发病机制尚未完全阐明,但似乎是多因素的。目前有抑制病毒复制的药物;然而,HBV采用的独特复制策略使病毒能够在受感染的肝细胞内持续存在。因此,很少能实现治愈。HBV研究和抗病毒药物临床前试验的进展受到病毒狭窄的物种和组织嗜性、可用感染模型的匮乏以及使用黑猩猩(唯一对HBV感染完全易感的动物)所带来的限制。小鼠对HBV不敏感,但主要努力集中在开发HBV复制和感染的小鼠模型,如人源化小鼠的产生。通过介绍现有的不同动物模型,本综述将突出从各个系统中获得的最重要和临床相关的发现。

相似文献

1
Animal models of HBV infection.乙型肝炎病毒感染的动物模型。
Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):273-279. doi: 10.1016/j.bpg.2017.04.014. Epub 2017 May 5.
2
Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.用于研究人类乙型肝炎病毒感染的体外和体内实验模型。
J Hepatol. 2016 Apr;64(1 Suppl):S17-S31. doi: 10.1016/j.jhep.2016.02.012.
3
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.用于研究乙型和丁型肝炎病毒相互作用及临床前药物评估的人源化嵌合 uPA 小鼠模型。
Hepatology. 2012 Mar;55(3):685-94. doi: 10.1002/hep.24758. Epub 2012 Jan 30.
4
Latest developments in the treatment of hepatitis B.乙型肝炎治疗的最新进展。
Minerva Gastroenterol Dietol. 2016 Mar;62(1):88-102. Epub 2015 Oct 8.
5
Modeling hepatitis B virus infection, immunopathology and therapy in mice.小鼠乙型肝炎病毒感染、免疫病理学及治疗的建模
Antiviral Res. 2015 Sep;121:1-8. doi: 10.1016/j.antiviral.2015.06.012. Epub 2015 Jun 19.
6
Mouse Models of Hepatitis B Virus Pathogenesis.乙型肝炎病毒发病机制的小鼠模型
Cold Spring Harb Perspect Med. 2015 Aug 20;5(11):a021477. doi: 10.1101/cshperspect.a021477.
7
Animal models for the study of human hepatitis B and D virus infection: New insights and progress.乙型和丁型肝炎病毒感染的动物模型研究:新的见解和进展。
Antiviral Res. 2020 Oct;182:104898. doi: 10.1016/j.antiviral.2020.104898. Epub 2020 Aug 3.
8
Small animal model systems for studying hepatitis B virus replication and pathogenesis.用于研究乙型肝炎病毒复制和发病机制的小动物模型系统。
Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760.
9
Mouse models of hepatitis B and delta virus infection.乙型肝炎和丁型肝炎病毒感染的小鼠模型。
J Immunol Methods. 2014 Aug;410:39-49. doi: 10.1016/j.jim.2014.03.002. Epub 2014 Mar 12.
10
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.进入抑制剂 Myrcludex-B 可有效阻止先前感染乙型肝炎病毒的人源化小鼠体内的病毒肝内扩散。
J Hepatol. 2013 May;58(5):861-7. doi: 10.1016/j.jhep.2012.12.008. Epub 2012 Dec 13.

引用本文的文献

1
An immune-based predictive model for HBV clearance: validation in multicenter cohorts and mechanistic insights from in vivo studies.一种基于免疫的乙肝病毒清除预测模型:多中心队列验证及体内研究的机制洞察
Virol J. 2025 May 21;22(1):153. doi: 10.1186/s12985-025-02792-w.
2
Replication and Expression of the Consensus Genome of Hepatitis B Virus Genotype C from the Chinese Population.中国人群乙型肝炎病毒 C 基因型共识基因组的复制和表达。
Viruses. 2023 Nov 23;15(12):2302. doi: 10.3390/v15122302.
3
Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies.
人源化肝脏 NSG-PiZ 小鼠支持慢性乙型肝炎病毒感染和抗病毒治疗的研究。
Microbiol Spectr. 2023 Jun 15;11(3):e0517622. doi: 10.1128/spectrum.05176-22. Epub 2023 May 18.
4
Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy.长期核苷(酸)治疗后,HBV DNA 低于检测下限的慢性乙型肝炎患者中持续的病毒复制和传染性病毒的产生。
PLoS One. 2022 Apr 1;17(4):e0262516. doi: 10.1371/journal.pone.0262516. eCollection 2022.
5
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models.临床阶段靶向凋亡抑制蛋白的药物可清除临床前模型中乙型肝炎病毒的游离基因组。
Cell Death Dis. 2021 Jun 23;12(7):641. doi: 10.1038/s41419-021-03924-0.
6
[Generation of a novel HBeAg transgenic mice using CRISPR/Cas9 technique].[利用CRISPR/Cas9技术构建新型乙型肝炎e抗原转基因小鼠]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Sep 30;39(9):1017-1022. doi: 10.12122/j.issn.1673-4254.2019.09.03.
7
Evolutionary biology of human hepatitis viruses.人类肝炎病毒的进化生物学。
J Hepatol. 2019 Mar;70(3):501-520. doi: 10.1016/j.jhep.2018.11.010. Epub 2018 Nov 23.
8
More than just oncogenes: mechanisms of tumorigenesis by human viruses.不只是癌基因:人类病毒引发肿瘤的机制。
Curr Opin Virol. 2018 Oct;32:48-59. doi: 10.1016/j.coviro.2018.09.003. Epub 2018 Sep 27.
9
Activity of nucleic acid polymers in rodent models of HBV infection.核酸聚合物在乙型肝炎病毒感染啮齿动物模型中的活性。
Antiviral Res. 2018 Jan;149:26-33. doi: 10.1016/j.antiviral.2017.10.022. Epub 2017 Nov 8.